PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for November 11, 2005 Subscribe to this News Feed    
 

ArtJen’s Impressive Weapon In The War On Obesity Now Available In Michigan’s SAV-ON Drug Stores

In anticipation of two Health Report News segments by the Detroit Fox TV network affiliate, ArtJen Complexus Holdings Corp. is pleased to announce that FBCx, its promising new weapon in the war on obesity, is now available in all SAV-ON Drug stores in Southeastern Michigan.

(PRWEB) November 11, 2005 -- In anticipation of two Health Report News segments by the Detroit Fox TV network affiliate, ArtJen Complexus Holdings Corp. is pleased to announce that FBCx, its promising new weapon in the war on obesity, is now available in all SAV-ON Drug stores in Southeastern Michigan. Prior to this agreement FBCx was available in Michigan only at Dr. George Grunberger’s office at 43494 Woodward, Bloomfield Hills, MI. Dr. Catherine Jen, President of ArtJen, states that the SAV-ON agreement will make FBCx more readily available to the public.

George Grunberger, M.D., K-L Catherine Jen, Ph.D. and Joseph Artiss, Ph.D. recently presented the findings of their clinical trial on volunteers with type 2 diabetes at both the June meeting of the American Diabetes Association and the October meeting of the North American Association for the Study of Obesity. Important conclusions to the Clinical Study include:

FBCx is effective in reducing and/or maintaining body weight in patients with type 2 diabetes.

FBCx is effective in reducing blood lipid levels in patients with elevated blood triglycerides.

FBCx can be easily incorporated into a diabetes management regimen.
FBCx was shown to bind more than 9 times its own weight in dietary fat in human volunteers.

Dr Grunberger, of the renowned Grunberger Diabetes Institute states that: “About 90 % of his patients with type 2 diabetes are obese and that obesity is the number 2 preventable cause of death in the U.S.” Before FBCx, “There was no known effective way to keep weight off.” Said Dr Grunberger “This discovery, which can help shed pounds or prevent weight gain, is a real progress.” Dr Jen said “Unlike claims made by others, this product actually works.”

The important results of this clinical trial could change the face of dietary management in patients with type 2 diabetes. Subjects in preclinical trials, including non diabetic patients showed dramatic and consistent weight loss. Many reported significant weight loss in the first few weeks and over 40 pounds of weight loss have been recorded. Employing a natural fiber each 1 gram tablet binds more than 9 grams of dietary fat effectively preventing the fat from being absorbed by the body. Dr. Artiss said: “There’s too much information to go into detail here, however, there is more scientific information available at our educational website: www.artjen.net.

By taking the recommended 2 tablets per typical North American meal results in a weight loss of 1 to 1.5 pounds per week. The product is now available under the FBCx name, Fat Binding Complexer. A US patent has been awarded to the ArtJen Company for FBCx, worldwide patents are pending.

FBCx is now available at SAV-ON Drug stores, Dr. Grunberger’s office (248-335-7740), on the web at www.artjen.net or by calling toll free 1-877-4-ARTJEN. FBCx is also available at select locations in Ontario; for a complete listing please visit www.artjen.net and click on “Shop In Person.”

For further information contact Dr. Joe Artiss at 1-519-919-0814.

###

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Joe Artiss
ARTJEN COMPLEXUS HOLDINGS CORP.
519-919-0814
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.